Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain | Journal of Medicinal Chemistry
![Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - ScienceDirect Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0887233315300217-gr1.jpg)
Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - ScienceDirect
![Ce@TiO2 nanocomposites: An efficient, stable and affordable photocatalyst for the photodegradation of diclofenac sodium - ScienceDirect Ce@TiO2 nanocomposites: An efficient, stable and affordable photocatalyst for the photodegradation of diclofenac sodium - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0925838817338963-fx1.jpg)
Ce@TiO2 nanocomposites: An efficient, stable and affordable photocatalyst for the photodegradation of diclofenac sodium - ScienceDirect
![Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology | Drugs Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology | Drugs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40265-015-0392-z/MediaObjects/40265_2015_392_Fig1_HTML.gif)
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology | Drugs
![Pharmaceutics | Free Full-Text | Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy Pharmaceutics | Free Full-Text | Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-00102/article_deploy/html/images/pharmaceutics-15-00102-g001.png)
Pharmaceutics | Free Full-Text | Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
![IJMS | Free Full-Text | Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration IJMS | Free Full-Text | Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration](https://www.mdpi.com/ijms/ijms-21-09452/article_deploy/html/images/ijms-21-09452-g001.png)
IJMS | Free Full-Text | Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration
![PDF) Diclofenac sodium 0.1% ophthalmic solution: Update on pharmacodynamics, clinical interest and safety profile PDF) Diclofenac sodium 0.1% ophthalmic solution: Update on pharmacodynamics, clinical interest and safety profile](https://i1.rgstatic.net/publication/233699222_Diclofenac_sodium_01_ophthalmic_solution_Update_on_pharmacodynamics_clinical_interest_and_safety_profile/links/0f3175399f8f96e05a000000/largepreview.png)
PDF) Diclofenac sodium 0.1% ophthalmic solution: Update on pharmacodynamics, clinical interest and safety profile
![IJMS | Free Full-Text | Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration IJMS | Free Full-Text | Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration](https://www.mdpi.com/ijms/ijms-21-09452/article_deploy/html/images/ijms-21-09452-g002.png)